Melatonin attenuates unilateral ureteral obstruction-induced renal injury by reducing oxidative stress, iNOS, MAPK, and NF-kB expression

Journal of Endourology

Volumn 23, Issue 7, 2009, Pages 1165-1173

  Ozbek, Emin ^a   Ilbey, Yusuf Ozlem ^a   Ozbek, Mustafa ^b   Simsek, Abdulmuttalip ^a   Cekmen, Mustafa ^c   Somay, Adnan ^d  

^a Bezm i Alem Valide Sultan Vakif Gureba Research and Education Hospital   (Turkey)

^b Diskapi Education and Research Hospital   (Turkey)

^c KOCAELI UNIVERSITY   (Turkey)

^d Bezm i Alem Valide Sultan Vakif Gureba Research and Education Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ALCOHOL; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MALONALDEHYDE; MELATONIN; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; HISTOPATHOLOGY; KIDNEY FIBROSIS; KIDNEY INJURY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; URETER LIGATION; URETER OBSTRUCTION;

ANIMALS; CELL MOVEMENT; FIBROSIS; GLUTATHIONE; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASES; LEUKOCYTES; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MELATONIN; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; RATS; RATS, WISTAR; URETERAL OBSTRUCTION;

EID: 67650835195     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2009.0035     Document Type: Article

References (60)

1. Sorenson EJ, Gillenwater JY. The renal hemodynamic response to chronic unilateral complete ureteral occlusion. Invest Urol 1970;8:78-90.
2. Schreiner GF, Harris KP, Purkerson ML, et al. Immunological aspects of acute ureteral obstruction: Immune cell infiltrate in the kidney. Kidney Int 1988;34:487-493.
3. Gulmi FAFD. Pathophysiology of urinary tract obstruction. In: Walsh PC, Retik AB, Vaughan ED Jr., et al, eds. Campbell's Urology. Philadelphia: W.B. Saunders, 2002, pp 434-443.
4. Ricardo SD, Ding G, Eufemio M, et al. Antioxidant expression in experimental hydronephrosis: Role of mechanical stretch and growth factors. Am J Physiol 1997;272:F789-F798. (Pubitemid 27382200)
5. Saborio P, Krieg RJ Jr., Kuemmerle NB, et al. Alpha-tocopherol modulates lipoprotein cytotoxicity in obstructive nephropathy. Pediatr Nephrol 2000;14:740-746. (Pubitemid 30462158)
6. Kawada N, Moriyama T, Ando A, et al. Increased oxidative stress in mouse kidneys with unilateral ureteral obstruction. Kidney Int 1999;56:1004-1013. (Pubitemid 29411727)
7. Klahr S. Urinary tract obstruction. Semin Nephrol 2001;21:133-145.
8. Fraga CG, Shigenaga MK, Park JW, et al. Oxidative damage to DNA during aging: 8-Hydroxy-2′-deoxyguanosine in rat organ DNA and urine. Proc Natl Acad Sci USA 1990;87:4533-4537. (Pubitemid 20204136)
9. Kasai H, Crain PF, Kuchino Y, et al. Formation of 8-hydroxyguanine moiety in cellular DNA by agents producing oxygen radicals and evidence for its repair. Carcinogenesis 1986;7:1849-1851.
10. Bogdan C. The multiplex function of nitric oxide in (auto) immunity. J Exp Med 1998;187:1361-1365. (Pubitemid 28215395)
11. Zaninotto F, La Camera S, Polverari A, et al. Cross talk between reactive nitrogen and oxygen species during the hypersensitive disease resistance response. Plant Physiol 2006;141:379-383. (Pubitemid 43974531)
12. Jiang F, Roberts SJ, Datla S, et al. NO modulates NADPH oxidase function via heme oxygenase-1 in human endothelial cells. Hypertension 2006;48:950-957. (Pubitemid 44611010)
13. de Pinto MC, Tommasi F, De Gara L, et al. Changes in the antioxidant systems as part of the signaling pathway responsible for the programmed cell death activated by nitric oxide and reactive oxygen species in tobacco Bright-Yellow 2 cells. Plant Physiol 2002;130:698-708. (Pubitemid 35224777)
14. Zhang C, Walker LM, Mayeux PR. Role of nitric oxide in lipopolysaccharide-induced oxidant stress in the rat kidney. Biochem Pharmacol 2000;59:203-209.
15. Yu TW, Anderson D. Reactive oxygen species-induced DNA damage and its modification: A chemical investigation. Mutat Res 1997;379:201-210. (Pubitemid 27450540)
16. Greggi Antunes LM, Darin JD, Bianchi MD. Protective effects of vitamin c against cisplatin-induced nephrotoxicity and lipid peroxidation in adult rats: A dose-dependent study. Pharmacol Res 2000;41:405-411.
17. Gilad E, Wong HR, Zingarelli B, et al. Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: Role of inhibition of NFkappaB activation. FASEB J 1998;12:685-693. (Pubitemid 28247147)
18. Barnes PJ, Karin M. Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066-1071. (Pubitemid 27163860)
19. Herlaar E, Brown Z. p38 MAPK signalling cascades in inflammatory disease. Mol Med Today 1999;5:439-447. (Pubitemid 29455026)
20. Chen CC, Wang JK. p38 but not p44/42 mitogen-activated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 macrophages. Mol Pharmacol 1999;55:481-488. (Pubitemid 29128104)
21. Gutiérrez-Venegas G,Maldonado-Frías S, Ontiveros-Granados A, et al. Role of p38 in nitric oxide synthase and cyclooxygenase expression, and nitric oxide and PGE2 synthesis in human gingival fibroblasts stimulated with lipopolysaccharides. Life Sci 2005;77:60-73. (Pubitemid 40552874)
22. Tan DX, Reiter RJ, Manchester LC, et al. Chemical and physical properties and potential mechanisms: Melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem 2002;2:181-197.
23. Tan DX, Manchester LC, Reiter RJ, et al. Significance of melatonin in antioxidative defense system: Reactions and products. Biol Signals Recept 2000;9:137-159.
24. Lissoni P, Tancini G, Barni S, et al. Treatment of cancer chemotherapy-induced toxicity with the pineal hormone melatonin. Support Care Cancer 1997;5:126-129. (Pubitemid 27163453)
25. Fadillioglu E, Kurcer Z, Parlakpinar H, et al. Melatonin treatment against remote organ injury induced by renal ischemia reperfusion injury in diabetes mellitus. Arch Pharm Res 2008;31:705-712.
26. Eşrefoǧlu M, Gül M, Parlakpinar H, et al. Effects of melatonin and caffeic acid phenethyl ester on testicular injury induced by myocardial ischemia/reperfusion in rats. Fundam Clin Pharmacol 2005;19:365-372. (Pubitemid 40769458)
27. Guerrero JM, Reiter RJ, Ortiz GG, et al. Melatonin prevents increases in neural nitric oxide and cyclic GMP production after transient brain ischemia and reperfusion in the Mongolian gerbil (Meriones unguiculatus). J Pineal Res 1997;23:24-31.
28. Montilla P, Túnez I, Muñoz MC, et al. Hyperlipidemic nephropathy induced by adriamycin: Effect of melatonin administration. Nephron 1997;76:345-350. (Pubitemid 27296539)
29. Pieri C, Moroni F, Marra M, et al. Melatonin is an efficient antioxidant. Arch Gerontol Geriatr 1995;20:159-165.
30. Livrea MA, Tesoriere L, D'Arpa D, et al. Reaction of melatonin with lipoperoxyl radicals in phospholipid bilayers. Free Radic Biol Med 1997;23:706-711. (Pubitemid 27364863)
31. Reiter RJ, Tan DX, Kim SJ, et al. Melatonin as a pharmacological agent against oxidative damage to lipids and DNA. Proc West Pharmacol Soc 1998;41:229-236. (Pubitemid 28549105)
32. Alonso M, Collado PS, González-Gallego J. Melatonin inhibits the expression of the inducible isoform of nitric oxide synthase and nuclear factor kappa B activation in rat skeletal muscle. J Pineal Res 2006;41:8-14. (Pubitemid 43980689)
33. Cuzzocrea S, Reiter RJ. Pharmacological actions of melatonin in acute and chronic inflammation. Curr Top Med Chem 2002;2:153-165.
34. Brzezinski A. Melatonin in humans. N Engl J Med 1997;336:186-195.
35. Cheung RT, Tipoe GL, Tam S, et al. Preclinical evaluation of pharmacokinetics and safety of melatonin in propylene glycol for intravenous administration. J Pineal Res 2006;41:337-343. (Pubitemid 44498219)
36. Pignone AM, Rosso AD, Fiori G, et al. Melatonin is a safe and effective treatment for chronic pulmonary and extrapulmonary sarcoidosis. J Pineal Res 2006;41:95-100. (Pubitemid 44141742)
37. Cassone VM, Chesworth MJ, Armstrong SM. Dose-dependent entrainment of rat circadian rhythms by daily injection of melatonin. J Biol Rhythms 1986;1:219-229.
38. Wasowicz W, Neve J, Peretz A. Optimized steps in fluorometric determination of thiobarbituric acid reactive substances in serum: Importance of extraction pH and influence of sample preservation and storage. Clin Chem 1993;39:2522-2528. (Pubitemid 24008241)
39. Moron MS, Depierre JW, Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 1979;582:67-78. (Pubitemid 9065588)
40. Lowry OH, Rosenbrough NJ, Farr AL, et al. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
41. Granger DL, Taintor RR, Boockvar KS, et al. Measurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction. Methods Enzymol 1999;268:142-151.
42. Moochhala S, Chhatwal VJ, Chan ST, et al. Nitric oxide synthase activity and expression in human colorectal cancer. Carcinogenesis 1996;17:1171-1174. (Pubitemid 26158422)
43. Nishida M, Okumura Y, Sato H, et al. Delayed inhibition of p38 mitogen-activated protein kinase ameliorates renal fibrosis in obstructive nephropathy. Nephrol Dial Transplant 2008;23:2520-2524.
44. Ma FY, Tesch GH, Flavell RA, et al. MKK3-p38 signaling promotes apoptosis and the early inflammatory response in the obstructed mouse kidney. Am J Physiol Renal Physiol 2007;293:F1556-F1563.
45. Stambe C, Atkins RC, Tesch GH, et al. The role of p38alpha mitogen-activated protein kinase activation in renal fibrosis. J Am Soc Nephrol 2004;15:370-379. (Pubitemid 38140777)
46. Nishida M, Okumura Y, Sato H, et al. Delayed inhibition of p38 mitogen-activated protein kinase ameliorates renal fibrosis in obstructive nephropathy. Nephrol Dial Transplant 2008;23:2520-2524.
47. Hashem RM, Soliman HM, Shaapan SF. Turmeric-based diet can delay apoptosis without modulating NF-kappaB in unilateral ureteral obstruction in rats. J Pharm Pharmacol 2008;60:83-89.
48. Meldrum KK, Metcalfe P, Leslie JA, et al. TNF-alpha neutralization decreases nuclear factor-kappaB activation and apoptosis during renal obstruction. J Surg Res 2006;131:182-188.
49. Tashiro K, Tamada S, Kuwabara N, et al. Attenuation of renal fibrosis by proteasome inhibition in rat obstructive nephropathy: Possible role of nuclear factor kappaB. Int J Mol Med 2003;12:587-592.
50. Hashem RM, Soliman HM, Shaapan SF. Turmeric-based diet can delay apoptosis without modulating NF-kappaB in unilateral ureteral obstruction in rats. J Pharm Pharmacol 2008;60:83-89.
51. Jang J, Park EY, Seo SI, et al. Effects of intravesical instillation of cyclooxygenase-2 inhibitor on the expression of inducible nitric oxide synthase and nerve growth factor in cyclophosphamide-induced overactive bladder. BJU Int 2006;98:435-439.
52. Notebaert S, Carlsen H, Janssen D, et al. In vivo imaging of NF-kappaB activity during Escherichia coli-induced mammary gland infection. Cell Microbiol 2008;10:1249-1258.
53. Pourazar J, Blomberg A, Kelly FJ, et al. Diesel exhaust increases EGFR and phosphorylated C-terminal Tyr 1173 in the bronchial epithelium. Part Fibre Toxicol 2008;5:1-8. (Pubitemid 351772884)
54. Chatterjee PK, Brown PA, Cuzzocrea S, et al. Calpain inhibitor-1 reduces renal ischemia/reperfusion injury in the rat. Kidney Int 2001;59:2073-2083. (Pubitemid 32467599)
55. Morrissey JJ, Klahr S. Rapid communication. Enalapril decreases nuclear factor kappa B activation in the kidney with ureteral obstruction. Kidney Int 1997;52:926-933.
56. Morrissey J, Klahr S. Transcription factor NF-kappaB regulation of renal fibrosis during ureteral obstruction. Semin Nephrol 1998;18:603-611. (Pubitemid 28506732)
57. Basireddy M, Isbell TS, Teng X, et al. Effects of sodium nitrite on ischemia-reperfusion injury in the rat kidney. Am J Physiol Renal Physiol 2006;290:F779-F786. (Pubitemid 43724935)
58. Noiri E, Nakao A, Uchida K, et al. Oxidative and nitrosative stress in acute renal ischemia. Am J Physiol Renal Physiol 2001;281:F948-F957. (Pubitemid 33123840)
59. Erdogan H, Fadillioglu E, Yagmurca M, et al. Protein oxidation and lipid peroxidation after renal ischemia-reperfusion injury: Protective effects of erdosteine and N-acetylcysteine. Urol Res 2006;34:41-46. (Pubitemid 43234713)
60. Rodríguez-Reynoso S, Leal C, Portilla-de Buen E, et al. Melatonin ameliorates renal ischemia/reperfusion injury. J Surg Res 2004;116:242-247. (Pubitemid 38180474)